emeis’ share price rises 34% after release of annual results

Pan-European listed French nursing home group emeis may have turned a corner in its long recovery from the scandal that hit the company in 2022. Its share price has climbed 34% since the release of its annual results on February 6, which emphasised improving occupancy and resident satisfaction despite net profit still being negative.

Assura rejects fourth takeover offer from KKR

Listed UK healthcare REIT Assura has rejected a fourth offer from US PE firm KKR. The most recent bid was a joint offer from KKR and UK pension fund Universities Superannuation Scheme (USS) of £1.56 billion (~$2 billion). Assura says this undervalues the REIT.

HBI Deals+Insights briefing February 2025: Intelligence members

Click here to download your Deals+Insights February 2025 briefing. In February’s issue we look at Polish labs group Diagnostyka’s IPO, Purehealth’s acquisition of Greek provider Hellenic Healthcare Group, Mehilainen’s acquisition of Lithuanian group InMedica, Optegra’s entry into the Netherlands, and the nationalisation of Deutsche Wohnen-owned German nursing home group PFLEGEN & WOHNEN. We also take […]

HBI Deals+Insights briefing February 2025: Deals+Insights members

Click here to download your Deals+Insights February 2025 briefing. In February’s issue we look at Polish labs group Diagnostyka’s IPO, Purehealth’s acquisition of Greek provider Hellenic Healthcare Group, Mehilainen’s acquisition of Lithuanian group InMedica, Optegra’s entry into the Netherlands, and the nationalisation of Deutsche Wohnen-owned German nursing home group PFLEGEN & WOHNEN. We also take […]

Muface crisis may be resolved by new funding increase offer

Muface, Spain’s health insurance scheme for civil servants and their families, may have been saved from extinction after its two main participants, private insurers Adlesas and Asisa, indicated they would agree to a 41.2% premium increase.

Diagnostyka IPO launches

Diagnostyka, Poland’s largest for-profit laboratory provider, has become a public company after listing on the Warsaw Stock Exchange.